GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » JD Health International Inc (HKSE:06618) » Definitions » Current Deferred Revenue

JD Health International (HKSE:06618) Current Deferred Revenue : HK$0 Mil (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is JD Health International Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

JD Health International's current deferred revenue for the quarter that ended in Dec. 2023 was HK$0 Mil.

JD Health International Current Deferred Revenue Historical Data

The historical data trend for JD Health International's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JD Health International Current Deferred Revenue Chart

JD Health International Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Current Deferred Revenue
Get a 7-Day Free Trial - - - - -

JD Health International Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

JD Health International Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of JD Health International's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

JD Health International (HKSE:06618) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » JD Health International Inc (HKSE:06618) » Definitions » Current Deferred Revenue
Comparable Companies
HKSE:06078 HKSE:02273 HKSE:01951 HKSE:01515 HKSE:00708 HKSE:03309 HKSE:06639 HKSE:02373 HKSE:02138 HKSE:02219 HCA SAU:4013 SZSE:300015 XTER:FRE BKK:BDMS XKLS:5225 BSP:RDOR3 XTER:FME UHS CHE
Traded in Other Exchanges
JDHIY:USA JDHIF:USA 8ZN:Germany
Address
No. 20 Kechuang 11 Street, Block C, Building 2, Jingdong Headquarters, Economic and Technological Development Zone, Daxing District, Beijing, CHN, 101111
Website
https://ir.jdhealth.com
JD Health is the largest healthcare e-commerce platform in China in terms of revenue. The company offers pharmaceutical drugs and healthcare products on its platform, both as a marketplace that connects merchants to consumers and as a first-party, or 1P, direct retailer. It also offers online consultation from real life doctors and separately partners with offline pharmacies that can provide location-based 24/7 delivery as part of an omnichannel initiative to complement its core e-commerce business. Its closest competitors are Alibaba Health, Ping An Good Doctor, and Meituan for its e-commerce business. As of Dec. 31, 2022, the platform has 154.3 million active annual users and over 70,000 merchants. JD Health is 67.49% owned by its parent company, JD.com.
Executives
Liu Qiangdong Richard 2101 Beneficial owner
Jd Jiankang Limited 2101 Beneficial owner
Jd.com, Inc. 2201 Interest of corporation controlled by you

JD Health International (HKSE:06618) Headlines

No Headlines